- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/74 - Major histocompatibility complex (MHC)
Patent holdings for IPC class C07K 14/74
Total number of patents in this class: 1695
10-year publication summary
|
39
|
94
|
105
|
124
|
187
|
248
|
243
|
294
|
247
|
68
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1144 |
500 |
| Cue Biopharma, Inc. | 151 |
73 |
| CRISPR Therapeutics AG | 361 |
54 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
45 |
| University Health Network | 979 |
36 |
| 10X Genomics, Inc. | 921 |
19 |
| Oregon Health & Science University | 746 |
15 |
| Sangamo Therapeutics, Inc. | 437 |
15 |
| Board of Regents, The University of Texas System | 5370 |
14 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1434 |
13 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 300 |
13 |
| The Regents of the University of California | 18943 |
12 |
| Imcyse SA | 69 |
12 |
| Xyphos Biosciences Inc. | 29 |
12 |
| Immunocore Limited | 190 |
11 |
| Albert Einstein College of Medicine, Inc. | 528 |
10 |
| Universite de Montreal | 341 |
10 |
| Gritstone bio, Inc. | 102 |
10 |
| Adaptimmune Limited | 179 |
9 |
| GigaGen, Inc. | 61 |
9 |
| Other owners | 803 |